Synthesis of 11-aminoalkoxy substituted benzophenanthridine derivatives as tyrosyl-DNA phosphodiesterase 1 inhibitors and their anticancer activity. 2022

Hao Yang, and Fang-Ting Wang, and Min Wu, and Wenjie Wang, and Keli Agama, and Yves Pommier, and Lin-Kun An
School of Pharmaceutical Sciences, Sun Yat-sen University, Guangzhou 510006, China.

Tyrosyl-DNA phosphodiesterase 1 (TDP1) is an enzyme that repairs DNA lesions caused by the trapping of DNA topoisomerase IB (TOP1)-DNA break-associated crosslinks. TDP1 inhibitors have synergistic effect with TOP1 inhibitors in cancer cells and can overcome cancer cell resistance to TOP1 inhibitors. Here, we report the synthesis of 11-aminoalkoxy substituted benzophenanthridine derivatives as selective TDP1 inhibitors and show that six compounds 14, 16, 18, 20, 25 and 27 exhibit high TDP1 inhibition potency. The most potent TDP1 inhibitor 14 (IC50 = 1.7 ± 0.24 μM) induces cellular TDP1cc formation and shows synergistic effect with topotecan in four human cancer cell lines MCF-7, A549, H460 and HepG2.

UI MeSH Term Description Entries
D010727 Phosphoric Diester Hydrolases A class of enzymes that catalyze the hydrolysis of one of the two ester bonds in a phosphodiester compound. EC 3.1.4. Phosphodiesterase,Phosphodiesterases,Hydrolases, Phosphoric Diester
D004264 DNA Topoisomerases, Type I DNA TOPOISOMERASES that catalyze ATP-independent breakage of one of the two strands of DNA, passage of the unbroken strand through the break, and rejoining of the broken strand. DNA Topoisomerases, Type I enzymes reduce the topological stress in the DNA structure by relaxing the superhelical turns and knotted rings in the DNA helix. DNA Nicking-Closing Protein,DNA Relaxing Enzyme,DNA Relaxing Protein,DNA Topoisomerase,DNA Topoisomerase I,DNA Topoisomerase III,DNA Topoisomerase III alpha,DNA Topoisomerase III beta,DNA Untwisting Enzyme,DNA Untwisting Protein,TOP3 Topoisomerase,TOP3alpha,TOPO IIIalpha,Topo III,Topoisomerase III,Topoisomerase III beta,Topoisomerase IIIalpha,Topoisomerase IIIbeta,DNA Nicking-Closing Proteins,DNA Relaxing Enzymes,DNA Type 1 Topoisomerase,DNA Untwisting Enzymes,DNA Untwisting Proteins,Topoisomerase I,Type I DNA Topoisomerase,III beta, Topoisomerase,III, DNA Topoisomerase,III, Topo,III, Topoisomerase,IIIalpha, TOPO,IIIalpha, Topoisomerase,IIIbeta, Topoisomerase,Topoisomerase III, DNA,Topoisomerase, TOP3,beta, Topoisomerase III
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D053119 Benzophenanthridines Compounds of four rings containing a nitrogen. They are biosynthesized from reticuline via rearrangement of scoulerine. They are similar to BENZYLISOQUINOLINES. Members include chelerythrine and sanguinarine.
D059004 Topoisomerase I Inhibitors Compounds that inhibit the activity of DNA TOPOISOMERASE I. DNA Topoisomerase I Inhibitor,DNA Topoisomerase III Inhibitor,DNA Topoisomerase III Inhibitors,DNA Type 1 Topoisomerase Inhibitor,DNA Type III Topoisomerase Inhibitor,DNA Type III Topoisomerase Inhibitors,Topoisomerase 1 Inhibitor,Topoisomerase 1 Inhibitors,Topoisomerase 3 Inhibitor,Topoisomerase 3 Inhibitors,Topoisomerase I Inhibitor,Topoisomerase III Inhibitor,Topoisomerase III Inhibitors,DNA Topoisomerase I Inhibitors,DNA Type 1 Topoisomerase Inhibitors,1 Inhibitor, Topoisomerase,3 Inhibitor, Topoisomerase,3 Inhibitors, Topoisomerase,I Inhibitor, Topoisomerase,III Inhibitor, Topoisomerase,III Inhibitors, Topoisomerase,Inhibitor, Topoisomerase 1,Inhibitor, Topoisomerase 3,Inhibitor, Topoisomerase I,Inhibitor, Topoisomerase III,Inhibitors, Topoisomerase 1,Inhibitors, Topoisomerase 3,Inhibitors, Topoisomerase I,Inhibitors, Topoisomerase III

Related Publications

Hao Yang, and Fang-Ting Wang, and Min Wu, and Wenjie Wang, and Keli Agama, and Yves Pommier, and Lin-Kun An
March 2023, International journal of molecular sciences,
Hao Yang, and Fang-Ting Wang, and Min Wu, and Wenjie Wang, and Keli Agama, and Yves Pommier, and Lin-Kun An
June 2020, Bioorganic & medicinal chemistry,
Hao Yang, and Fang-Ting Wang, and Min Wu, and Wenjie Wang, and Keli Agama, and Yves Pommier, and Lin-Kun An
March 2018, Molecules (Basel, Switzerland),
Hao Yang, and Fang-Ting Wang, and Min Wu, and Wenjie Wang, and Keli Agama, and Yves Pommier, and Lin-Kun An
September 2011, Expert opinion on therapeutic patents,
Hao Yang, and Fang-Ting Wang, and Min Wu, and Wenjie Wang, and Keli Agama, and Yves Pommier, and Lin-Kun An
September 2021, Phytotherapy research : PTR,
Hao Yang, and Fang-Ting Wang, and Min Wu, and Wenjie Wang, and Keli Agama, and Yves Pommier, and Lin-Kun An
July 2019, Medicinal research reviews,
Hao Yang, and Fang-Ting Wang, and Min Wu, and Wenjie Wang, and Keli Agama, and Yves Pommier, and Lin-Kun An
February 1981, Journal of medicinal chemistry,
Hao Yang, and Fang-Ting Wang, and Min Wu, and Wenjie Wang, and Keli Agama, and Yves Pommier, and Lin-Kun An
May 2018, European journal of medicinal chemistry,
Hao Yang, and Fang-Ting Wang, and Min Wu, and Wenjie Wang, and Keli Agama, and Yves Pommier, and Lin-Kun An
December 2021, Molecules (Basel, Switzerland),
Hao Yang, and Fang-Ting Wang, and Min Wu, and Wenjie Wang, and Keli Agama, and Yves Pommier, and Lin-Kun An
April 2017, Journal of medicinal chemistry,
Copied contents to your clipboard!